The solid‐state structure of the β‐blocker metoprolol: a combined experimental and in silico investigation

Metoprolol {systematic name: (RS)‐1‐isopropylamino‐3‐4‐(2‐methoxyethyl)phenoxy]propan‐2‐ol}, C₁₅H₂₅NO₃, is a cardioselective β₁‐adrenergic blocking agent that shares part of its molecular skeleton with a large number of other β‐blockers. Results from its solid‐state characterization by single‐crystal and variable‐temperature powder X‐ray diffraction and differential scanning calorimetry are presented. Its molecular and crystal arrangements have been further investigated by molecular modelling, by a Cambridge Structural Database (CSD) survey and by Hirshfeld surface analysis. In the crystal, the side arm bearing the isopropyl group, which is common to other β‐blockers, adopts an all‐trans conformation, which is the most stable arrangement from modelling data. The crystal packing of metoprolol is dominated by an O—H…N/N…H—O pair of hydrogen bonds (as also confirmed by a Hirshfeld surface analysis), which gives rise to chains containing alternating R and S metoprolol molecules extending along the b axis, supplemented by a weaker O…H—N/N—H…O pair of interactions. In addition, within the same stack of molecules, a C—H…O contact, partially oriented along the b and c axes, links homochiral molecules. Amongst the solid‐state structures of molecules structurally related to metoprolol deposited in the CSD, the β‐blocker drug betaxolol shows the closest analogy in terms of three‐dimensional arrangement and interactions. Notwithstanding their close similarity, the crystal lattices of the two drugs respond differently on increasing temperature: metoprolol expands anisotropically, while for betaxolol, an isotropic thermal expansion is observed.